Kaikai Yu

588 total citations
22 papers, 440 citations indexed

About

Kaikai Yu is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Kaikai Yu has authored 22 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Immunology and 4 papers in Cancer Research. Recurrent topics in Kaikai Yu's work include Toxin Mechanisms and Immunotoxins (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Immune Response and Inflammation (3 papers). Kaikai Yu is often cited by papers focused on Toxin Mechanisms and Immunotoxins (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Immune Response and Inflammation (3 papers). Kaikai Yu collaborates with scholars based in China, Germany and Canada. Kaikai Yu's co-authors include Feng Qian, Yudong Hu, Lei Sun, Depeng Zhang, Yunhe Ding, Huiqiong He, Yaxian Wu, Zishu Wang, Fang Su and Yang Yang and has published in prestigious journals such as Nature Communications, Biochemical Pharmacology and EMBO Reports.

In The Last Decade

Kaikai Yu

20 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaikai Yu China 10 229 111 80 76 45 22 440
Yunhe Ding China 9 159 0.7× 99 0.9× 74 0.9× 51 0.7× 38 0.8× 14 357
Zunyong Feng China 14 342 1.5× 147 1.3× 118 1.5× 78 1.0× 40 0.9× 21 558
Yanqin Qin China 10 250 1.1× 112 1.0× 88 1.1× 103 1.4× 26 0.6× 18 493
Yanxia Li China 13 291 1.3× 70 0.6× 106 1.3× 40 0.5× 71 1.6× 25 463
Wei‐Heng Xu China 16 302 1.3× 70 0.6× 71 0.9× 35 0.5× 79 1.8× 31 630
Tiejian Zhao China 8 251 1.1× 50 0.5× 76 0.9× 60 0.8× 49 1.1× 17 511
Hongmei Piao China 11 139 0.6× 113 1.0× 31 0.4× 54 0.7× 32 0.7× 18 365
Xinru Jiang China 10 274 1.2× 94 0.8× 180 2.3× 28 0.4× 39 0.9× 17 495

Countries citing papers authored by Kaikai Yu

Since Specialization
Citations

This map shows the geographic impact of Kaikai Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaikai Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaikai Yu more than expected).

Fields of papers citing papers by Kaikai Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaikai Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaikai Yu. The network helps show where Kaikai Yu may publish in the future.

Co-authorship network of co-authors of Kaikai Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Kaikai Yu. A scholar is included among the top collaborators of Kaikai Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaikai Yu. Kaikai Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Yan, Xinyu Geng, Kaikai Yu, et al.. (2025). ANG‐Modified Liposomes Coloaded With α‐Melittin and Resveratrol Induce Apoptosis and Pyroptosis in Glioblastoma Cells by Impeding Wnt/β‐Catenin Signaling. CNS Neuroscience & Therapeutics. 31(5). e70437–e70437. 5 indexed citations
2.
Liu, Zhiying, Guan Wang, Zhiqi Sun, et al.. (2024). KANK1 promotes breast cancer development by compromising Scribble-mediated Hippo activation. Nature Communications. 15(1). 10381–10381. 2 indexed citations
3.
Xu, Yuxin, Yan Wang, Na Zhao, et al.. (2024). Caspase-3/Gasdermin E-mediated pyroptosis contributes to Ricin toxin-induced inflammation. Toxicology Letters. 396. 19–27.
4.
Yu, Kaikai, et al.. (2024). The USP12/46 deubiquitinases protect integrins from ESCRT-mediated lysosomal degradation. EMBO Reports. 25(12). 5687–5718.
5.
Yu, Haotian, Na Zhao, Yan Wang, et al.. (2023). Anti-ricin toxin human neutralizing antibodies and DMAbs protection against ricin toxin poisoning. Toxicology Letters. 383. 152–161. 2 indexed citations
6.
Zhang, Xiaohao, Haotian Yu, Yan Wang, et al.. (2021). CircEpc1 Promotes Ricin Toxin-Induced Inflammation via Activation of NF-κB and MAPK Signaling Pathways by Sponging miR-5114. Frontiers in Pharmacology. 12. 767900–767900. 5 indexed citations
7.
Liu, Zhongliang, Xiaohao Zhang, Meng Xu, et al.. (2021). Analysis of the microRNA and mRNA expression profile of ricin toxin-treated RAW264.7 cells reveals that miR-155-3p suppresses cell inflammation by targeting GAB2. Toxicology Letters. 347. 67–77. 8 indexed citations
8.
Yu, Kaikai, Haotian Yu, Yan Wang, et al.. (2021). Identification of a lncRNA/circRNA-miRNA-mRNA network to explore the effects of ricin toxin-induced inflammation in RAW264.7 cells. Toxicon. 203. 129–138. 5 indexed citations
9.
Xu, Na, Kaikai Yu, Haotian Yu, et al.. (2020). Recombinant Ricin Toxin Binding Subunit B (RTB) Stimulates Production of TNF-α by Mouse Macrophages Through Activation of TLR4 Signaling Pathway. Frontiers in Pharmacology. 11. 526129–526129. 5 indexed citations
10.
Chen, Tingting, Yong Wang, Yang Yang, et al.. (2019). Gramicidin inhibits human gastric cancer cell proliferation, cell cycle and induced apoptosis. Biological Research. 52(1). 57–57. 24 indexed citations
11.
Chen, Yong, et al.. (2019). Ginkgo biloba Extract Protects Mesenteric Arterioles of Old Rats via Improving Vessel Elasticity through Akt/FoxO3a Signaling Pathway. Annals of Vascular Surgery. 57. 220–228. 4 indexed citations
12.
Wang, Zishu, Kaikai Yu, Yudong Hu, et al.. (2019). Schisantherin A induces cell apoptosis through ROS/JNK signaling pathway in human gastric cancer cells. Biochemical Pharmacology. 173. 113673–113673. 46 indexed citations
13.
Nie, Yunjuan, Kaikai Yu, Boyu Li, et al.. (2019). S-allyl-l-cysteine attenuates bleomycin-induced pulmonary fibrosis and inflammation via AKT/NF-κB signaling pathway in mice. Journal of Pharmacological Sciences. 139(4). 377–384. 23 indexed citations
14.
Zhang, Jian, et al.. (2019). Investigation of BRAF mutation in a series of papillary thyroid carcinoma and matched-lymph node metastasis with ARMS PCR. Pathology - Research and Practice. 215(4). 761–765. 5 indexed citations
15.
Du, Yao, Bo Zhao, Kaikai Yu, et al.. (2019). Costunolide alleviates HKSA-induced acute lung injury via inhibition of macrophage activation. Acta Pharmacologica Sinica. 40(8). 1040–1048. 25 indexed citations
16.
Li, Yu, Depeng Zhang, Kaikai Yu, et al.. (2018). CMPD1 inhibited human gastric cancer cell proliferation by inducing apoptosis and G2/M cell cycle arrest. Biological Research. 51(1). 11–11. 26 indexed citations
17.
Zhang, Depeng, Yudong Hu, Yaxian Wu, et al.. (2018). Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination. Biochemical Pharmacology. 154. 183–192. 69 indexed citations
18.
Hu, Yudong, Kaikai Yu, Gang Wang, et al.. (2018). Lanatoside C inhibits cell proliferation and induces apoptosis through attenuating Wnt/β-catenin/c-Myc signaling pathway in human gastric cancer cell. Biochemical Pharmacology. 150. 280–292. 66 indexed citations
19.
Wu, Yaxian, Shen Yao, Yunhe Ding, et al.. (2018). Protostemonine attenuates alternatively activated macrophage and DRA-induced asthmatic inflammation. Biochemical Pharmacology. 155. 198–206. 29 indexed citations
20.
Ding, Yunhe, Yaxian Wu, Huiqiong He, et al.. (2018). Isoalantolactone suppresses LPS-induced inflammation by inhibiting TRAF6 ubiquitination and alleviates acute lung injury. Acta Pharmacologica Sinica. 40(1). 64–74. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunhe Ding Breakdown of academic impact, for papers by Zunyong Feng Breakdown of academic impact, for papers by Yanqin Qin Breakdown of academic impact, for papers by Yanxia Li Breakdown of academic impact, for papers by Wei‐Heng Xu Breakdown of academic impact, for papers by Tiejian Zhao Breakdown of academic impact, for papers by Hongmei Piao Breakdown of academic impact, for papers by Xinru Jiang
Rankless by CCL
2026